Skip to main content
BFRI logo
BFRI
(NASDAQ)
Biofrontera Inc.
$0.98-- (--)
Loading... - Market loading

Biofrontera (BFRI) Stock Price & Financial Analysis

Biofrontera Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$0.88 - $0.99
52-Week High$1.19
52-Week Low$0.54
Open$0.88
Volume129.64K
Average Volume (3M)129.64K
Market Cap10.56M
Shares Outstanding10.78M
Price to Sales (P/S)0.27
EV/EBITDA-0.70
Revenue (TTM)37.16M
Net Income (TTM)-17.57M
Free Cash Flow (TTM)-12.01M
EPS (TTM)$-1.63
Profit Margin-47.28%
Operating Margin-47.40%
50-Day MA$0.88
200-Day MA$0.88
52-Week Change15.26%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Biofrontera

What is the current stock price for BFRI?

As of the latest trading session, BFRI stock trades at $0.98. The 52-week range is $0.54–$1.19, with a day range of $0.88–$0.99.

What is the P/E ratio for BFRI?

The P/E ratio (Price-to-Earnings) for BFRI is shown in the Key Statistics section. This valuation metric helps compare Biofrontera Inc. to industry peers.

Does BFRI pay dividends?

Biofrontera does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for BFRI?

Based on 1 analyst, the consensus for BFRI is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of BFRI?

Biofrontera's market capitalization is $10.6M, classifying it as a micro-cap company. Biofrontera operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.